Synapse - Immunology Program Faculty

Results (174)

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

Journal Article

Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
Journal of Clinical Investigation (2023)

Fulltext@MSK | Save

The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT

Journal Article

Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
Blood Advances (2022)

Fulltext@MSK | Save

Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation

Journal Article

Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
Advances in Cell and Gene Therapy (2021)

Fulltext@MSK | Save

Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes

Meeting Abstract

Trillo, R. A.; Recio, M. G.; Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; more...
Bone Marrow Transplantation (2020)

Fulltext@MSK | Save

High progression-free survival after intermediate intensity double unit cord blood transplantation in adults

Journal Article

Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
Blood Advances (2020)

Fulltext@MSK | Save

Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism

Meeting Abstract

O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation

Meeting Abstract

Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores

Meeting Abstract

Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066

Meeting Abstract

O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

Journal Article

Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
Journal of Clinical Investigation (2020)

Fulltext@MSK | Save